ObjectiveTo investigate the feasible of aldosterone on screening metabolic syndrome (MS). MethodsA total of 600 participants who were admitted into our hospital from 2010 to 2015 were selected as study subjects, including 300 males and 300 females, aged from 30-70 years, the data of the participants were completed. The level of aldosterone of all subjects were detected. With the diagnostic criterion of MS by World Health Organization(WHO) and Chinese Medical Association(CMA) Diabetes Branch as golden criterion to compare the feasible of aldosterone in screening MS. ResultsAs a golden criterion with WHO diagnostic criterion, the diagnostic veracity rate of aldosterone in the diagnosis of male MS and female MS were both 94.33%; by the gold standard of the CMA diagnostic criterion, the diagnostic veracity rate of aldosterone in the diagnosis of male MS and female MS were 94.67%, 94.33%, respectively. ConclusionsAldosterone on screening and diagnosing metabolic syndrome is feasible.

无